Pantoprazol Holsten (Pantoprazole Sodium Sesquihydrate)

Pantoprazole Sodium Sesquihydrate, the active ingredient in Pantoprazol Holsten, is a proton pump inhibitor presented as a tablet for oral use. It reduces stomach acid production and is used to treat acid‑related disorders such as gastro‑oesophageal reflux disease and peptic ulcer disease in adults.

GNH USA supplies Pantoprazol Holsten as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Pantoprazol Holsten is a proton pump inhibitor that acts on the gastric acid secretion pathway. It is indicated for several acid‑related conditions: - Gastro‑oesophageal reflux disease (GERD): provides symptomatic relief and promotes healing of the oesophageal lining. - Erosive oesophagitis: accelerates mucosal healing and reduces further erosion. - Peptic ulcer disease: supports ulcer healing and helps prevent recurrence. - Zollinger‑Ellison syndrome: controls excessive gastric acid secretion associated with the condition.

Adverse reactions to pantoprazole may vary in frequency and severity.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhoea: usually self‑limiting. - Nausea: occasional and transient. - Abdominal pain: mild discomfort. - Flatulence: excess gas formation. - Constipation: infrequent bowel changes.

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis): rash, swelling, breathing difficulty. - Clostridioides difficile infection: persistent watery diarrhoea. - Acute interstitial nephritis: kidney inflammation presenting with reduced urine output. - Low magnesium levels (hypomagnesemia): muscle cramps, irregular heartbeat. - Bone fractures: increased risk with long‑term use. - Liver enzyme elevation: abnormal liver function tests.

When prescribing Pantoprazol Holsten, consider the following safety measures: - Assess renal function: dose adjustment may be needed in severe impairment. - Review hepatic status: monitor if liver disease is present. - Evaluate need for long‑term therapy: prolonged use is linked to bone density loss. - Monitor electrolytes: especially magnesium during extended treatment. - Avoid abrupt discontinuation: taper to prevent rebound acid hypersecretion. - Store below 25°C: keep in the original container, protect from moisture and direct sunlight.

Pantoprazol Holsten can affect the pharmacokinetics of several co‑administered medicines.

Major Interactions (Avoid): - Ketoconazole or itraconazole: reduced antifungal absorption. - Atazanavir: markedly decreased antiviral exposure. - Clopidogrel: diminished antiplatelet effect.

Moderate Interactions (Monitor Closely): - Warfarin: potential increase in INR, monitor coagulation. - Methotrexate: possible accumulation, check serum levels. - Digoxin: slight rise in serum concentration, observe for toxicity.